Quantcast
Home > Quotes > CLSD

Clearside Biomedical, Inc. Common Stock (CLSD) Quote & Summary Data

CLSD 
$1.26
*  
0.04
3.08%
Get CLSD Alerts
*Delayed - data as of Dec. 14, 2018  -  Find a broker to begin trading CLSD now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    CLSD Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
Today's High / Low
$ 1.36 / $ 1.26
Share Volume
346,317
50 Day Avg. Daily Volume
501,256
Previous Close
$ 1.30
52 Week High / Low
$ 15.329 / $ 1.26
Market Cap
40,350,521
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %

Intraday Chart

Shares Traded

Share Volume:
346,317
50 Day Avg. Daily Volume:
501,256

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -2.67

Trading Range

The current last sale of $1.26 Equals the 52 week low.

Intraday Last 52 Weeks
High: $ 1.36 $ 15.329
 Low: $ 1.26 $ 1.26

Company Description (as filed with the SEC)

We are a late-stage clinical biopharmaceutical company developing first-in-class pharmacological therapies to treat blinding diseases of the eye. Our current product candidates focus on diseases affecting the retina, which is the tissue that lines the inside of the eye and is primarily responsible for vision, and the choroid, which is the layer adjacent to the retina that supplies the retina with blood, oxygen and nourishment. With our proprietary microinjector, drugs are injected into and spread through the suprachoroidal space, or SCS, which is the space located between the choroid and the outer protective layer of the eye known as the sclera. With the suprachoroidal injection, our product candidates are more directly administered to the retina and choroid as compared to other ocular drug administration techniques such as injections of drug into the vitreous, a jelly-like substance that occupies the central portion of the eye.  ... More ...  


Risk Grade

Where does CLSD fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 1.29
Open Date:
Dec. 14, 2018
Close Price:
$ 1.26
Close Date:
Dec. 14, 2018

Consensus Recommendation

Analyst Info